24C.F C-RAD AB B

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
2.10 EUR
Close of Nov 11, 2026
1.77 3.38
Market cap
EUR 66.8M
P/E
17.0x
P/B
1.87x
ROE
16.4%
Dividend yield
0.45%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 24C.F undervalued?

Graham number
Price2.10
Graham value1.76
Premium18.9%

24C.F trades 18.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

C-RAD AB B fundamental analysis

No fundamental analysis for C-RAD AB B yet.

C-RAD AB B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About C-RAD AB B

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+…

Full company profile